Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 30, 2016
Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)
T Valentin, A Le Cesne, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 24, 2015
Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)
E Bompas, A Le Cesne, E Tresch-Bruneel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 18, 2008
Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group
A Italiano, N Penel, Y-M Robin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial
L Belin, M Kamal, C Mauborgne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2011
Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival
A Italiano, M Toulmonde, A Cioffi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 11, 2014
Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group
A T Falk, L Moureau-Zabotto, M Ouali, et al.
Presse Medicale (Paris, France : 1983)
|
February 25, 2000
[Leukemia and pre-leukemic conditions occurring after treatment of breast cancer]
B Cutuli, M Janvier, A de la Rochefordière, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 14, 2019
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)
P Pautier, N Penel, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2014
Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: a randomized controlled open-label trial
A Adenis, J-Y Blay, B Bui-Nguyen, et al.
ESMO Open
|
July 29, 2021
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery
P Pautier, A Floquet, C Chevreau, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
European Journal of Cancer (Oxford, England : 1990)
|
January 30, 2016
Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)
T Valentin, A Le Cesne, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 24, 2015
Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)
E Bompas, A Le Cesne, E Tresch-Bruneel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 18, 2008
Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group
A Italiano, N Penel, Y-M Robin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial
L Belin, M Kamal, C Mauborgne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2011
Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival
A Italiano, M Toulmonde, A Cioffi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 11, 2014
Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group
A T Falk, L Moureau-Zabotto, M Ouali, et al.
Presse Medicale (Paris, France : 1983)
|
February 25, 2000
[Leukemia and pre-leukemic conditions occurring after treatment of breast cancer]
B Cutuli, M Janvier, A de la Rochefordière, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 14, 2019
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)
P Pautier, N Penel, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2014
Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: a randomized controlled open-label trial
A Adenis, J-Y Blay, B Bui-Nguyen, et al.
ESMO Open
|
July 29, 2021
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery
P Pautier, A Floquet, C Chevreau, et al.
Page
of 6